477 related articles for article (PubMed ID: 18302356)
1. Data mining a small molecule drug screening representative subset from NIH PubChem.
Xie XQ; Chen JZ
J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356
[TBL] [Abstract][Full Text] [Related]
2. Introduction of a generally applicable method to estimate retrieval of active molecules for similarity searching using fingerprints.
Vogt M; Bajorath J
ChemMedChem; 2007 Sep; 2(9):1311-20. PubMed ID: 17562536
[TBL] [Abstract][Full Text] [Related]
3. Learning from the data: mining of large high-throughput screening databases.
Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
[TBL] [Abstract][Full Text] [Related]
4. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
Piras P; Roussel C
J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
[TBL] [Abstract][Full Text] [Related]
5. Bioisosteric similarity of molecules based on structural alignment and observed chemical replacements in drugs.
Krier M; Hutter MC
J Chem Inf Model; 2009 May; 49(5):1280-97. PubMed ID: 19402687
[TBL] [Abstract][Full Text] [Related]
6. Representation of chemical information in OASIS centralized 3D database for existing chemicals.
Nikolov N; Grancharov V; Stoyanova G; Pavlov T; Mekenyan O
J Chem Inf Model; 2006; 46(6):2537-51. PubMed ID: 17125194
[TBL] [Abstract][Full Text] [Related]
7. Data mining PubChem using a support vector machine with the Signature molecular descriptor: classification of factor XIa inhibitors.
Weis DC; Visco DP; Faulon JL
J Mol Graph Model; 2008 Nov; 27(4):466-75. PubMed ID: 18829357
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of a novel class-directed 2D fingerprint to search for structurally diverse active compounds.
Eckert H; Bajorath J
J Chem Inf Model; 2006; 46(6):2515-26. PubMed ID: 17125192
[TBL] [Abstract][Full Text] [Related]
9. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
[TBL] [Abstract][Full Text] [Related]
10. How do 2D fingerprints detect structurally diverse active compounds? Revealing compound subset-specific fingerprint features through systematic selection.
Heikamp K; Bajorath J
J Chem Inf Model; 2011 Sep; 51(9):2254-65. PubMed ID: 21793563
[TBL] [Abstract][Full Text] [Related]
11. A similarity-based data-fusion approach to the visual characterization and comparison of compound databases.
Medina-Franco JL; Maggiora GM; Giulianotti MA; Pinilla C; Houghten RA
Chem Biol Drug Des; 2007 Nov; 70(5):393-412. PubMed ID: 17927720
[TBL] [Abstract][Full Text] [Related]
12. Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints.
Kumar A; Siddiqi MI
J Mol Graph Model; 2008 Nov; 27(4):476-88. PubMed ID: 18829358
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial library enumeration and lead hopping using comparative interaction fingerprint analysis and classical 2D QSAR methods for seeking novel GABA(A) alpha(3) modulators.
Vijayan RS; Bera I; Prabu M; Saha S; Ghoshal N
J Chem Inf Model; 2009 Nov; 49(11):2498-511. PubMed ID: 19891421
[TBL] [Abstract][Full Text] [Related]
14. Large-scale annotation of small-molecule libraries using public databases.
Zhou Y; Zhou B; Chen K; Yan SF; King FJ; Jiang S; Winzeler EA
J Chem Inf Model; 2007; 47(4):1386-94. PubMed ID: 17608408
[TBL] [Abstract][Full Text] [Related]
15. Chemical database mining through entropy-based molecular similarity assessment of randomly generated structural fragment populations.
Batista J; Bajorath J
J Chem Inf Model; 2007; 47(1):59-68. PubMed ID: 17238249
[TBL] [Abstract][Full Text] [Related]
16. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures.
Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
Org Biomol Chem; 2004 Nov; 2(22):3256-66. PubMed ID: 15534703
[TBL] [Abstract][Full Text] [Related]
17. A family of ring system-based structural fragments for use in structure-activity studies: database mining and recursive partitioning.
Nilakantan R; Nunn DS; Greenblatt L; Walker G; Haraki K; Mobilio D
J Chem Inf Model; 2006; 46(3):1069-77. PubMed ID: 16711726
[TBL] [Abstract][Full Text] [Related]
18. Bayesian screening for active compounds in high-dimensional chemical spaces combining property descriptors and molecular fingerprints.
Vogt M; Bajorath J
Chem Biol Drug Des; 2008 Jan; 71(1):8-14. PubMed ID: 18069988
[TBL] [Abstract][Full Text] [Related]
19. Charting, navigating, and populating natural product chemical space for drug discovery.
Lachance H; Wetzel S; Kumar K; Waldmann H
J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
[TBL] [Abstract][Full Text] [Related]
20. Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds.
Baurin N; Baker R; Richardson C; Chen I; Foloppe N; Potter A; Jordan A; Roughley S; Parratt M; Greaney P; Morley D; Hubbard RE
J Chem Inf Comput Sci; 2004; 44(2):643-51. PubMed ID: 15032546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
